Search Results 381-390 of 16768 for GLP-1 agonists

  1. A Study to Assess the Effect of Smart Insulin Pens on Glycemic Control and Diabetes-related Burdens - Mayo Clinic

    The objectives of this study are to determine whether the InPen® alters the glycemic control and variability in adolescents and emerging adults with type 1 ...

  2. Sodium phenylbutyrate (oral route) - Side effects & dosage - Mayo Clinic

    If the medicine is mixed with food, it should be taken right away. However, if it is mixed with water, the solution can be stored for up to one week at room ...

  3. Too much of a good thing can be dangerous, finds researchers investigating hypoglycemia

    McCoy says that people who have multiple chronic health conditions, are older, have Type 1 diabetes, or are treated with medications such as insulin or ...

  4. A Phase 1 Study Of Anitocabtagene Autoleucel For The Treatment Of Subjects With Non-oncology Plasma Cell-related Diseases - Mayo Clinic

    A Phase 1 dose-escalation study designed to evaluate the safety, tolerability, and preliminary efficacy of anito-cel in subjects with generalized myasthenia ...

  5. Trifluridine and tipiracil (oral route) - Side effects & dosage - Mayo Clinic

    At first, 35 milligrams (mg) per square meter [m(2)] of body size 2 times a day, taken on Days 1 to 5, and Days 8 to 12 of every 28-day cycle. Your doctor ...

  6. Acetylcysteine (inhalation route) - Mayo Clinic

    If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. ... Adults and children—1 to 2 mL of ...

  7. COVID-19 pill gets advisory panel approval - Mayo Clinic News Network

    The first oral antiviral medication to treat COVID-19 is one step closer. A Food and Drug Administration (FDA) advisory panel has voted to recommend ...

  8. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety ... Subjects receiving Gonadotropin-releasing hormone (GnRH) agonists and antagonists are allowed to participate.

  9. Pancreas Transplant - Eligibility - Mayo Clinic

    People with type 1 diabetes often may be candidates for a pancreas transplant. Some people with type 2 diabetes and post-total pancreatectomy diabetes may ...

  10. Study Of GI-102 And PD-1 In Glioblastoma - Mayo Clinic

    The purpose of this study to assess pharmacodynamic (PD) changes in tumor tissue. Participation eligibility. Participant eligibility includes age, gender, type ...